Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
Yan Hu,Jingjing Li,Haifeng Luo,Wenli Song,Jiyuan Yang
DOI: https://doi.org/10.2147/IJGM.S321265
IF: 2.145
2021-09-17
International Journal of General Medicine
Abstract:Yan Hu, Jingjing Li, Haifeng Luo, Wenli Song, Jiyuan Yang Department of Oncology, The First People's Hospital of Jingzhou, Jingzhou, Hubei, 434000, People's Republic of China Correspondence: Yan Hu Department of Oncology, The First People's Hospital of Jingzhou, Jingzhou, Hubei, 434000, People's Republic of China Tel +86 716 8513623 Email Background: Gastric cancer (GC) is among the most prevalent cancers globally. As such, there is a need to explore the mechanism underlying its pathogenesis and identify potential biomarkers for its prognosis. Methods: ONCOMINE was used to screen differentially expressed genes between GC and normal gastric mucosa. GEPIA was used to analyze the expression and correlation of candidate genes in tumor node metastasis (TNM) stage. STRING was used to construct protein interaction network. Kaplan–Meier plotter was used to analyze survival. TIMER was used to evaluate the association between candidate genes and immune cell infiltration. Results: From the ONCOMINE database, we found COL1A1, COL1A2, COL6A3, and SULF1 genes were significantly upregulated in stomach adenocarcinomas. There was a considerable correlation between the expression of COL1A1 (p = 0.029), COL1A2 (p = 0.004), COL6A3 (p = 0.002), SULF1 (p = 0.001), and the TNM stage. COL1A1 was positively correlated with ERBB2 (R = − 0.037, p = 0.46), while the other three genes were negatively correlated with ERBB2 (p > 0.05). The Kaplan–Meier plotter showed that low transcriptional levels of COL1A1 (p = 0.0020), COL1A2 (p = 0.0015), COL6A3 (p = 0.0015), and SULF1 (p = 0.0016) in gastric cancer patients were remarkably related to longer overall survival. In addition, there was a close relationship between chemokine expression and infiltration of the six immune cell types: B cells, macrophages, CD4+ T cells, CD8+ T cells, dendritic cells, and neutrophils, implying that the genes acted as indicators of both prognosis and immune status. Conclusion: Our findings implicate COL1A1, COL1A2, COL6A3, and SULF1 as candidate biomarkers for the prognosis of gastric cancer. Keywords: gastric cancer, biomarker, prognosis Gastric cancer (GC) is among the most prevalent cancers worldwide. The highest gastric cancer incidence rates occur in East Asia, South and Central America, and Eastern Europe. 1 Rates of GC are exceptionally high in Japan and Korea, where it is the most common cancer in men, and in China, where it is the most common cause of cancer-associated death. 2 Globally, there were about 1.03 million cases of GC, which led to the deaths of over 780,000 people in 2018, indicating that the disease is the fifth most prevalent and the third most common cause of cancer-associated deaths worldwide. 3,4 According to their anatomic location and histologic type, over 95% of GC are categorized as adenocarcinomas. 5 The main reason for the short overall survival (OS) and poor prognosis of gastric cancer patients is that the patients can not be diagnosed early. Advanced gastric cancer patients still account for a large proportion. Nowadays, various progressive treatment methods can not bring good curative effect for patients with advanced gastric cancer. Early diagnosis is still the primary and extremely important means to reduce the mortality of gastric cancer patients. So far, the diagnosis of gastric cancer in the world mainly depends on the pathological biopsy of gastroscope, but it is very difficult to carry out large-scale pathological biopsy. In addition, patients with gastric cancer have no specific clinical symptoms, especially early gastric cancer, which is easy to miss diagnosis. 6 The lack of sensitive and specific predictive factors for gastric cancer diagnosis is the fundamental reason why gastric cancer patients can not be diagnosed early. Therefore, it is very important to find high specificity and sensitivity biomarkers for early diagnosis and prognosis of gastric cancer. 7 Bioinformatics analysis, which can screen out the key genes related to diseases, has been widely used in clinical disease research. 8,9 How to further analyze the existing data resources with bioinformatics has become a research hotspot in cancer and bioinformatics. Herein, we employed many open databases to analyze the expression of COL1A1, COL1A2, COL6A3, and SULF1 in gastric cancer and assess their potential application as prognostic markers and therapeutic targets. Our results provide theoretical basis for further study of the molecular mechanism of gastric cancer and its diagnosis and prognosis. We obtained the microarrays data from the ONCOMINE database ( www.oncomine.org ) and identified five datasets involving COL1A1, COL1A2, COL6A3, and SULF1 after using the following filters: -Abstract Truncated-
medicine, general & internal